This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: AMGN BIIB DWA FCX ULTI

Stocks in this article: AMGN BIIB DWA FCX ULTI

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Amgen (AMGN) was upgraded at Goldman Sachs to buy from neutral. $130 price target. Company was also added to the Conviction Buy List, as the company has multiple potential catalysts, Goldman said.

Biogen Idec (BIIB) was downgraded at Goldman Sachs to neutral from buy. $215 price target. Valuation call, as the stock is up 44% since December, Goldman said.

CapitalSource (CSE) was downgraded to hold at TheStreet Ratings.

Dreamworks (DWA) was upgraded at Bank of America/Merrill Lynch to neutral. $22 price target. Company appears to be at a positive inflection point, BofA/Merrill said.

Freeport-McMoran (FCX) was upgraded at Nomura to buy from neutral. $38 price target. Company prices appear oversold, and valuation multiples should expand, Nomura said.

Fiserv (FISV) was downgraded at Oppenheimer to perform from outperform. Valuation call, based on an $89 price target, Oppenheimer said.


LSI (LSI) was downgraded at Goldman Sachs to neutral from buy. $7 price target. Company is leveraged to weak enterprise spending and lower PC demand, Goldman Sachs said.

Nuance (NUAN) was downgraded at Morgan Stanley to equal-weight. Company is facing increased growth risks, Morgan Stanley said.

Oil States (OIS) was downgraded at BMO Capital to underperform. Valuation call, based on an $82 price target, BMO Capital said.

Oneok (OKE) was downgraded at Morgan Stanley to equal-weight. $53 price target. Stock is up 20% year to date, despite deteriorating fundamentals, Morgan Stanley said.

Opko Health (OPK) was downgraded to hold at TheStreet Ratings.


Ultimate Software (ULTI) was upgraded at Canaccord Genuity to buy. $110 price target. Company is carrying a lot of momentum into the new year, Canaccord said.

STOCK COMMENTS/EPS CHANGES

Aetna (AET) estimates, price target were raised at BMO Capital. Shares are now seen reaching $64. Estimates were also increased, given improving core trends, BMO Capital said. Outperform rating.

Artisan Partners Asset Management (APAM) price target and estimates were increased at Citigroup. Solid flows, underlying margin dynamics and favorable FCF, said Citigroup. Price target goes to $47.

Avon (AVP) estimates, price target were boosted at BMO Capital. Shares are now seen reaching $27. Estimates were also increased, as the company is realizing higher margins, BMO Capital said. Outperform rating.


1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs